Related Experiment Video

Updated: Sep 16, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Creutzfeld-Jakob disease: the Grace General Hospital experience

F Pauls1, J Hayes, J Read

  • 1Salvation Army Grace General Hospital, Winnipeg.

Leadership in Health Services = Leadership Dans Les Services De Sante
|October 4, 1996
PubMed

Insights

Winnipeg hospitals faced a decision on informing patients exposed to a blood product from a Creutzfeldt-Jakob disease donor. The Salvation Army Grace Hospital chose to inform patients, prioritizing their right to health information and informed consent for donations.

Area of Science:

  • Medical Ethics
  • Public Health
  • Neurology

Background:

  • A patient received a blood product from a donor diagnosed with Creutzfeldt-Jakob disease (CJD).
  • Hospitals in Winnipeg grappled with the ethical dilemma of patient notification regarding potential CJD transmission risk.

Purpose of the Study:

  • To evaluate the ethical considerations and decision-making process regarding informing patients exposed to CJD-contaminated blood products.
  • To analyze the rationale behind the Salvation Army Grace Hospital's decision to disclose the risk to affected patients.

Main Methods:

  • Case study analysis of a specific hospital's response to a potential CJD exposure event.
  • Review of ethical principles related to patient autonomy, informed consent, and public trust in healthcare.

Main Results:

  • The Salvation Army Grace Hospital decided to inform patients of the potential risk, however small.
  • Key factors influencing the decision included patients' fundamental right to health information and the need for informed consent regarding future blood or organ donations.

Conclusions:

  • Prioritizing patient rights and transparency is crucial in managing risks associated with rare but serious diseases like CJD.
  • Maintaining public trust in the healthcare system necessitates open communication, especially following significant inquiries like the Krever inquiry.

Keywords:
Professional Patient RelationshipSalvation Army Grace General Hospital (Winnipeg)

More Related Videos

Prion Safety Laboratory Swipe Test06:01

Prion Safety Laboratory Swipe Test

Published on: February 14, 2025

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants06:02

Experimental Approaches for Biochemical Analysis of Glial Fibrillary Acidic Protein and Its Disease-associated Variants

Published on: November 28, 2025

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...